Nanomol
    Technologies

  • The company
  • Successful cases
  • R+D
  • Clients
  • News
  • Contact

    Particle
    technologies

  • Delos enabled products
  • Benefits and advantages
  • Partnering
  • Delos nanovesicles
  • Solid particulate materials

    Contract
    analysis

  • Services
  • Analysis
  • Quality
  • Expertise and equipment
Back to the gallery

News

DELOS FORMULATION TECHNOLOGY, THE BEST OPTION FOR YOUR NANOMEDICINES
15 November 2021

DELOS FORMULATION TECHNOLOGY, THE BEST OPTION FOR YOUR NANOMEDICINES

As the report in Farmaindustria magazine indicates, incremental innovation in medicines is a growing need, both for patients and healthcare professionals. This has the essential purpose of facilitating the use and efficacy of medicines, and, especially, of improving the quality of life of people. 

For this reason, drug reformulation technologies such as #DELOS are increasingly relevant in the sector. Incremental innovations are meeting an increasing demand and help in different aspects, which we could summarize in four: providing faster action, ease of use, and improvements in the efficacy and adherence of patients to their treatments. In addition, through incremental innovation, new routes of administration, and improvements in safety or dosage, can also be discovered, as well as the combination of two or more active ingredients that allow to use them more effectively. 

At Nanomol Technologies we have developed our own formulation technology called DELOS. #DELOS enables the development of advanced nanomedicines and tailored drug delivery systems. We are able to stabilize and improve the performance of #APIs, from small chemical molecules to biologics , including peptides, proteins and intracellular delivery of nucleic acids, of interest to our partners, enabling new routes of administration or improved drug products. 

If you are looking for an improvement in the formulation of your drug products, our technology can offer you many advantages in the market. 

Related
news

NANOMOL TECHNOLOGIES AT THE 15TH  MEETING OF EUROPEAN TECHNOLOGY PLATFORM ON NANOMEDICINE AND THE 14TH MEDITERRANEAN CONGRESS OF CHEMICAL ENGINEERING 29 October 2020

NANOMOL TECHNOLOGIES AT THE 15TH MEETING OF EUROPEAN TECHNOLOGY PLATFORM ON NANOMEDICINE AND THE 14TH MEDITERRANEAN CONGRESS OF CHEMICAL ENGINEERING

Nanomol Technologies has been Advertised on the “Spotlight on Catalonia” of Nature Journal 15 December 2016

Nanomol Technologies has been Advertised on the “Spotlight on Catalonia” of Nature Journal

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug 28 February 2021

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality

Copyright © 2023

Nanomol Technologies S.L.

Site by Suki

This website uses cookies.